[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Forestier et al., 1986 - Google Patents

Prenatal diagnosis of hemophilia by fetal blood sampling under ultrasound guidance

Forestier et al., 1986

Document ID
7262437659882500319
Author
Forestier F
Daffos F
Sole Y
Rainaut M
Publication year
Publication venue
Haemostasis

External Links

Snippet

In utero fetal blood sampling was performed in 55 cases for prenatal diagnosis of hemophilia A and B. Fifteen fetuses were found to be affected. However, with this new procedure, it was possible to demonstrate that fetuses were not hemophiliacs in 40 cases …
Continue reading at karger.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

Similar Documents

Publication Publication Date Title
Daffos et al. Fetal blood sampling via the umbilical cord using a needle guided by ultrasound report of 66 cases
Nilsson et al. Intrauterine death and circulating anticoagulant (“antithromboplastin”)
Daffos et al. Fetal blood, sampling during pregnancy with use of a needle guided by ultrasound: A study of 606 consecutive cases
Forestier et al. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation
Weinstein et al. Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura
Kociba Bovine plasma thromboplastin antecedent (Factor XI) deficiency
Olson et al. Evaluation of ristocetin–Willebrand factor assay and ristocetin-induced platelet aggregation
Holmberg et al. Coagulation in the human fetus: Comparison with term newborn infants
Forestier et al. Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy
Holmberg et al. Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX
JP2003505678A (en) Method for measuring coagulation factor activity in whole blood
Mibashan et al. Dual diagnosis of prenatal haemophilia A by measurement of fetal factor VIIIC and VIIIC antigen (VIIICAg)
Kadir et al. Hemostatic disorders in women
Forestier et al. Prenatal diagnosis of hemophilia by fetal blood sampling under ultrasound guidance
Halimeh et al. PBAC score: an easy-to-use tool to predict coagulation disorders in women with idiopathic heavy menstrual bleeding
Kisker et al. Development of blood coagulation—a fetal lamb model
Fass et al. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease
Shirahata et al. Diagnosis of DIC in very low birth weight infants
Melissari et al. Protein S and C4b‐binding protein in fetal and neonatal blood
Terwiel et al. Coagulation factors in the human fetus of about 20 weeks of gestational age
Stiehm et al. Split products of fibrin in the serum of newborns
Brackenridge et al. Distributions, sex and age effects, and joint associations between phenotypes of 14 genetic systems in an Australian population sample
Forestier Some aspects of fetal biology
Ma et al. Evaluation of the bleeding patient
de Gennes et al. Direct fetal blood examination for prenatal diagnosis of homozygous familial hypercholesterolemia.